Up­dat­ed: Mod­er­na ramps up R&D spend in RSV, flu and cy­tomegalovirus in Q2

Last year
Pharma

GSK, Pfiz­er head in­to patent du­el in high-stakes RSV vac­cine war

Last year
Pharma
Law

Ex­clu­sive: Tech VC firm Play­ground Glob­al deep­ens biotech fo­cus, hires for­mer a16z part­ner with next fund com­ing

Last year
People
Financing

Kyver­na Ther­a­peu­tics adds $60M to the bank as it pre­pares to show­case ear­ly CAR-T da­ta in lu­pus nephri­tis

Last year
Financing
Cell/Gene Tx

Rep­re­sen­ta­tives con­cerned over DSC­SA im­ple­men­ta­tion and sup­ply chain dis­rup­tion

Last year
FDA+
Manufacturing

Medicare may save $1.8B from four drugs in first year of price ne­go­ti­a­tions, re­search finds

Last year
Pharma

FDA ap­proves Tai­ho's Lon­surf with be­va­cizum­ab for metasta­t­ic col­orec­tal can­cer

Last year
Pharma
FDA+

BeiGene's BTK in­hibitor brings in $308M, dri­ves Q2 earn­ings with 46% in­crease from Q1

Last year
Pharma

Third in line: Ed­i­tas says it may part­ner up on com­mer­cial­iza­tion of sick­le cell gene ther­a­py

Last year
Pharma
Cell/Gene Tx

Out­sourc­ing com­pa­ny Ster­Rx to shut New York plant and lay off 161 em­ploy­ees due to ‘eco­nom­ic’ rea­sons

Last year
People
Manufacturing

Te­va sees rev­enue in­creas­es in Q2 as it con­tin­ues its ‘piv­ot to growth’ dri­ve

Last year
Pharma
Manufacturing

NIH taps in­fec­tious dis­ease doc­tor Jeanne Mar­raz­zo to suc­ceed Fau­ci as NI­AID head

Last year
People

Steve Job­s' son to lead Emer­son Col­lec­tive's on­col­o­gy-fo­cused VC firm Yosemite

Last year
Financing
Startups

A broad new idea for treat­ing vi­ral in­fec­tions: blow­ing up their pro­tec­tive mem­branes

Last year
R&D
Discovery

CG On­col­o­gy reels in $105M crossover for po­ten­tial late 2024 blad­der can­cer drug fil­ing

Last year
Financing
Startups

Il­lu­mi­na and Guardant agree to dis­miss lit­i­ga­tion, share spec­i­men sam­ples af­ter year-long le­gal bat­tle

Last year
Law

Mar­tin Shkre­li's old com­pa­nies se­cure $650,000 deal to sell Dara­prim amid bank­rupt­cy

Last year
Deals
Pharma

In­ter­galac­tic Ther­a­peu­tics, a non-vi­ral gene ther­a­py biotech, lays off all em­ploy­ees

Last year
People
Startups

Ver­tex dos­es first pa­tient with next type 1 di­a­betes cell ther­a­py pro­gram, while padding its cof­fers with strong Q2

Last year
R&D

Pro­QR finds eye dis­ease part­ner in Eu­rope, hands off two late-stage can­di­dates

Last year
Deals
Pharma

Com­mon can­cer drug man­u­fac­tur­er warned by the FDA over da­ta in In­dia

Last year
Pharma
FDA+

Ab­b­Vie, Lund­beck ask FDA to re­vise draft guid­ance on mi­graine drugs

Last year
Pharma
FDA+

Hen­ri­et­ta Lack­s' fam­i­ly set­tles lit­i­ga­tion with Ther­mo Fish­er for undis­closed amount over im­mor­tal cells

Last year
Pharma

FDA and DEA call on AD­HD drug man­u­fac­tur­ers to up pro­duc­tion amid on­go­ing short­ages

Last year
FDA+
Manufacturing
First page Previous page 302303304305306307308 Next page Last page
A service from the Financial Times